Sunday, Nov. 22, 2026 A Vik Media Group publication
Mongevity Longevity in Motion
Leer en español

Colorectal cancer study in mice links a mouth bacterium to faster tumor growth

Colorectal cancerPart of a story we are following · 6 articles · See every update
A plate of fresh raw vegetables, including lettuce, tomato and cucumber, on a banana leaf.
A plate of fresh raw vegetables, including lettuce, tomato and cucumber, on a banana leaf.Photo: Bajinra / Wikimedia Commons, CC0

If you worry about colorectal cancer, here is where this news stands: it comes from mice and lab work, it has not been tested in people, and it changes nothing about your care today. It does point at a new question researchers want to answer.

In a study using mice, human stool samples and human tumor tissue, a bacterium called Bifidobacterium dentium (B. dentium) traveled from under the gums to tumors, sped up their growth and made them resist chemotherapy drugs. In people with colorectal cancer, higher amounts of this bacterium inside the tumor were linked to poorer survival.

How the study worked

Scientists first looked for bacteria in stool samples from people with melanoma and colorectal cancer, and in tumor tissue from both cancers. They then tested B. dentium in mouse models, including one with a colorectal tumor grown in the colon. The work was published on November 9, 2026 in Cell Reports Medicine. Most of the experiments were done in mice and cells, so the results cannot yet tell us what happens in people.

What did the researchers find?

The team found B. dentium in stool samples from people with melanoma and colorectal cancer, and they could detect it inside tumor tissue from both cancers. Among people with colorectal cancer, those with more of this bacterium in their tumors had poorer survival. That is a link, not proof that the bacterium caused it.

The mouse experiments went further. When live B. dentium was given under the gums of mice, the bacteria found their way to tumors. The tumors then grew faster. This happened with two kinds of tumor cells, including a colorectal tumor model grown in the colon.

The researchers also looked at what the bacterium does once it gets there:

  • It enters tumor cells.
  • It pushes the cells to multiply, through two growth signals called Akt and ERK.
  • It switches on a protein called MMP3, which makes the cancer more able to spread.
  • It makes the cells less sensitive to key chemotherapy drugs.

The chemo effect has its own chain of events. The bacterium makes a chemical called GABA. In the study, GABA turned on a gene switch called FOXA2, which raised levels of a protein called P-gp. P-gp contributes to chemotherapy resistance.

The authors describe B. dentium as a “pathobiont.” That means a microbe that can live in the body without trouble in some places, but acts as a troublemaker in the right setting. They call it “niche-dependent,” meaning it seems to cause harm only in certain spots, such as inside a tumor.

What is still unknown?

A lot. The study does not show that B. dentium causes tumors to grow or resist chemo in people. It does not show that the mouth is the route in people, since the mice received the bacterium under the gums by design. It also does not say how common this bacterium is in people with colorectal cancer, or whether removing it would help patients.

The authors call B. dentium a potential target for improving cancer treatment response. That is a direction for future research, not a treatment that exists.

What you can do today

Nothing about your care changes because of this study. There is no test for this bacterium that you need to ask about, and nothing here tells you to alter your routine. If you are in screening or treatment, keep following the plan you and your care team set.

If the news left you uneasy, that is a normal reaction to a headline about bacteria and cancer. For now it is early science, and researchers will need studies in people before anyone knows whether it matters for patients.

For clinicians and researchers

Design: Preclinical study combining human data (fecal samples from patients with melanoma and colorectal cancer, plus melanoma and CRC tissue) with mouse models (CT26 and B16F10 tumors, including an orthotopic CT26 colorectal model) given live B. dentium subgingivally. Sample sizes are not given in the abstract.

Main result: Subgingival live B. dentium was associated with accelerated CT26 and B16F10 tumor growth in mice. High intratumoral B. dentium abundance correlated with poorer survival in CRC patients. No effect sizes or confidence intervals are given in the abstract.

Main limitation: Causal evidence comes from mouse models only; the human data are correlative, and the abstract reports no sample sizes, so generalizability to patients is untested.

How it fits: Adds a microbial, tumor-biology angle to earlier Mongevity coverage of colorectal cancer treatment (liver surgery, rectal organ preservation), which dealt with clinical management rather than bacteria. Keyhole surgery for colorectal cancer in the liver means fewer complications · Colorectal cancer: more rectal patients keep their bowel and skip surgery

Open question: Whether B. dentium eradication or inhibition of the GABA-FOXA2-P-gp axis improves chemotherapy response in patients remains to be tested.

Got a question? Ask us ›

Get the best of longevity science by emailThe most useful new studies, in plain language and with the source. Free.

We'll email you once to confirm. Occasional messages from our sponsors, clearly labeled. Unsubscribe anytime. We never ask for health data.
Cite this article
AMA
Mongevity Desk. Colorectal cancer study in mice links a mouth bacterium to faster tumor growth. Mongevity. Published November 22, 2026. Accessed November 22, 2026. https://mongevity.science/cancer/2026/11/colorectal-cancer-bacterium-mice-tumor-growth/
Vancouver
Mongevity Desk. Colorectal cancer study in mice links a mouth bacterium to faster tumor growth [Internet]. Mongevity; 2026 Nov 22 cited 2026 Nov 22]. Available from: https://mongevity.science/cancer/2026/11/colorectal-cancer-bacterium-mice-tumor-growth/
APA
Mongevity Desk. (2026, November 22). Colorectal cancer study in mice links a mouth bacterium to faster tumor growth. Mongevity. https://mongevity.science/cancer/2026/11/colorectal-cancer-bacterium-mice-tumor-growth/
For your website
<a href="https://mongevity.science/cancer/2026/11/colorectal-cancer-bacterium-mice-tumor-growth/">Colorectal cancer study in mice links a mouth bacterium to faster tumor growth</a>

Free to share or quote with credit and a link.

Questions and answers

Does this study show a mouth bacterium causes colorectal cancer in people?
No. Most of the experiments were done in mice and cells. In people, the study only found that more of this bacterium in colorectal tumors was linked to poorer survival.
What is Bifidobacterium dentium?
It is a bacterium the researchers found in stool samples and tumor tissue from people with melanoma and colorectal cancer. They describe it as a pathobiont, a microbe that can act as a troublemaker in the right setting.
How did the bacterium make chemo work less well in the study?
It makes a chemical called GABA, which turned on a gene switch called FOXA2. That raised a protein called P-gp, which contributes to chemotherapy resistance.
Should I change anything because of this study?
No. The study does not test any action for people. Keep following the screening or treatment plan you and your care team set.

Sources

  1. Cell Rep Med: Tumor-colonizing Bifidobacterium dentium promotes tumor progression and chemotherapy resistance via MMP3 and GABA-FOXA2-P-gp axis (PMID 43003090 · DOI 10.1016/j.xcrm.2026.103142) · 2026-11-22

More on this story

Report an error